🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

529 results for “Teva” Clear

  1. Amlodipine-benazepril 10 mg-20 mg capsules

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  2. An open label, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence study comparing Mesalamine delayed release capsules 400 mg manufactured by Sun Pharmaceutical Industries Limited, India with Mesalamine Delayed-Release Capsules 400 mg, manufactured for Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, in healthy, adult, human subjects under fasting condition.

    Lacuna Pharma Pty Ltd

    ulcerative colitis

    phase 1 other active

    1 trial

  3. An open label, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence study comparing Mesalamine delayed release capsules 400 mg manufactured by Sun Pharmaceutical Industries Limited, India with Mesalamine Delayed-Release Capsules 400 mg, manufactured for Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, in healthy, adult, human subjects under fed condition.

    Lacuna Pharma Pty Ltd

    ulcerative colitis

    phase 1 other active

    1 trial

  4. An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of Single Entity Amphetamine Product) 30 mg, manufactured by Frontida Biopharm. Inc., Philadelphia, USA with Attent 30 mg (Mixed Amphetamine Salts tablets) manufactured by Teva Israel Ltd., in healthy adult, human subjects under fasting condition.

    Lacuna Pharma Pty Ltd

    ADHD

    phase 1 other active

    1 trial

  5. Anastrozole

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  6. Anastrozole (Teva Pharmaceuticals USA)

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  7. Arsenic trioxide

    Teva Pharma GmbH

    Chronic Myelogenous Leukemia

    phase 1 small molecule terminated

    1 trial

  8. Azithromycin

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  9. Azithromycin 600 mg Tablet

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  10. BDP HFA Nasal Aerosol

    Teva Pharma GmbH

    Allergic Rhinitis

    phase 1 small molecule completed

    1 trial

  11. BUSPAR® 30 mg Tablet

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  12. Beclomethasone dipropionate BAI

    Teva Pharma GmbH

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  13. Benazepril HCl 40 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  14. Bicalutamide

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  15. Buprenorphine

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  16. Bupropion HCl

    Teva Pharma GmbH

    Depressive Disorder

    phase 1 small molecule terminated

    1 trial

  17. CD56-Enriched Donor Lymphocyte Infusion

    Teva Pharma GmbH

    Multiple Myeloma

    phase 1 mab completed

    1 trial

  18. CEP-11981 (kinase inhibitor)

    Teva Pharma GmbH

    Cancer

    phase 1 small molecule completed

    1 trial

  19. CEP-26401

    Teva Pharma GmbH

    Cognitive Impairment

    phase 1 small molecule completed

    1 trial

  20. CEP-37250/KHK2804

    Teva Pharma GmbH

    Solid Tumour

    phase 1 small molecule completed

    1 trial

  21. CEP-37251

    Teva Pharma GmbH

    Bone Loss

    phase 1 small molecule terminated

    1 trial

  22. CEP-37440

    Teva Pharma GmbH

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  23. CEP-9722

    Teva Pharma GmbH

    Solid Tumor

    phase 1 small molecule completed

    1 trial

  24. CEP-9722

    Teva Pharma GmbH

    Solid Tumors or Mantle Cell Lymphoma

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources